Health Management

Patients and their oncologists are weighing the pros and cons of delaying treatment. Once the outbreak subsides, how might the practice of oncology change?

A study of patients with inflammatory conditions who were prescribed biologic disease-modifying anti-rheumatic drugs had lower rates of chronic opioid use if they were adherent to their biologic therapy, according to new research.

Medical and dental care in the United States are like estranged colleagues: nominally on the same team but rarely, if ever, in touch with each other. Some value-based payment arrangements may start to mend the rift, which could both improve overall health and reduce healthcare costs.

FDA today approved Tecentriq (atezolizumab) as an initial treatment for adults with metastatic non-small cell lung cancer (NSCLC) for certain patients with high programmed-death ligand-1 (PD-L1) expression, marking the fifth approval of the immunotherapy in lung cancer and the fourth in advanced NSCLC.

The purpose of biosimilar is simple: reduce healthcare costs, pure and simple. Here are 11 trends affecting biosimilars over the last year in the U.S.

Residents and staff have been hit hard by the disease. PPE is in short supply. The deaths are taking an emotional toll on largely unheralded workers.

If American healthcare does wind up getting divided into pre- and post-COVID-19 eras, the migration from in-person visits to telehealth ones will likely be one of the biggest developments on the right-hand side of the inflection.

You have a highly trained, hardworking and fundamentally altruistic workforce. Don’t squander it.

Lili Brillstein, CEO of BCollaborative and member of the Managed Healthcare Executive® editorial advisory board discusses how the global shut-down and stay-at-home orders due to the COVID-19 pandemic have benefitted us in many ways.

There are a variety of medications being studied for the COVID-19, and the possible treatment landscape is rapidly evolving.

Videoconferencing reduced anxiety and stress among “distance caregivers,” according to the results of randomized trial scheduled to be presented at the annual meeting of the American Society of Clinical Oncology.

Medicaid expansion under the Affordable Care Act resulted in a decrease in cancer mortality rates that translated into 785 fewer cancer deaths in 2017 expansion states, according to results of a study scheduled to be presented at annual meeting of American Society of Clinical Oncology (ASCO), which is now scheduled to be held virtually May 29-31 instead of in Chicago.

Testing remains ongoing in the search for treatment drugs and a vaccine for COVID-19.

Dr. Mark Ruchman, chief medical officer, Versant Health, shares eye safety tips and ways to best stay protected from COVID-19 as guidelines are loosened throughout the country.

The onset of COVID-19 has doubled the percentage of American adults who have tried telemedicine as an alternative to a doctor’s office visit.

Dr. Robert Posner, who specializes in helping people lose weight, offers preparedness advice.

The Advanced Medical Technology Association (AdvaMed) recently announced availability of a new “Code of Ethics Compliance Guidance Related to the COVID-19 Response.”

Dr. Vivek Garg, CareMore and Aspire chief medical officer, discusses palliative home-based care and its effects of COVID-19.

All across the country, and in fact globally, musculoskeletal (MSK) care has become difficult if not impossible for most patients to access because of the COVID-19 pandemic.

As employers plan to return to the workplace, Mercer survey reveals key considerations from employers’ experience with essential workers and COVID-19.

The FDA recently approved AstraZeneca’s Farxiga (dapagliflozin) for the treatment of heart failure with reduced ejection fraction (HFrEF) in adults with and without type 2 diabetes, marking the first time a drug in a class developed for diabetes was approved for heart failure even if diabetes is not present.

The Whole Person Care pilot program has proven to be essential for communities in California and could potentially do the same in communities around the world.

Two-year follow up of FOURIER study in 22,655 patients confirms neurocognitive safety of very low LDL-C levels using a patient self-survey tool.

Healthcare providers and payers are keeping an eye on unemployment rates across the country and in communities that have been affected the most because the rates will have an effect on the use of medical services and insurance coverage. Here is a look at some of the economies most affected.

Researchers have reported a signicant and positive relationship between the amount of virus present in a throat swab sample and the severity of COVID-19 disease.